Company
Thermo Fisher Scientific
Official Name: Thermo Fisher Scientific Inc.
Headquarters: Waltham, MA, United States
Founded: 1956
Employees: 130,000
CEO: Mr. Marc N. Casper
Market Cap
$207.62 Billion
USD as of Jan. 1, 2024
Thermo Fisher Scientific Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Company Description
Thermo Fisher Scientific Inc. dedicated to biological and medical diagnostics and research. It manufactures and distributes scientific and medical instruments, laboratory equipment, software, reagents, consumables, chemicals, and services. Segmented into life sciences, analytical instruments, specialty diagnostics, and laboratory products, Thermo Fisher caters to the needs of multiple pharmaceuticals, biotechnology, agricultural, clinical, academic, and government actors.
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Danaher | $171.89 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
| IQVIA Holdings Inc. | $40.16 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Thermo Fisher Scientific Inc. has the following listings and related stock indices.
Stock: NYSE: TMO wb_incandescent
Stock: BCBA: TMO wb_incandescent
Stock: BMV: TMO wb_incandescent
Stock: Bovespa: TMOS34 wb_incandescent
Stock: MTA: TN8 wb_incandescent
Stock: XETR: TN8 wb_incandescent
Product & Services
Analytical/other equipment and instruments, laboratory reagents and consumables, science software and services—for research, discovery, analysis, and manufacturing (incl. pharmaceutical and diagnostic products)
Key People
Marc N. Casper (President & CEO) Mark Stevenson (COO) Ryan Snyder (CIO)
Financials
Revenue: US$32.21 billion (2020)
Operating income: US$7.794 billion (2020)
Net income: US$6.375 billion (2020)
Total assets: US$69.052 billion (2020)
Total equity: US$34.507 billion (2020)